|
Orthologous residues
|
|
smMLCK (human): S1773‑p, smMLCK iso2 (human): S1704‑p, smMLCK (mouse): S1795‑p, smMLCK (rat): S1804‑p, smMLCK (rabbit): S1005‑p, smMLCK (chicken): S1762‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
[32P] bio-synthetic labeling, mutation of modification site
|
|
Relevant cell lines - cell types - tissues:
'muscle, skeletal'
|
|
Cellular systems studied:
tissue
|
|
Species studied:
rabbit
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
forskolin
|
|
|
|
increase
|
|
|
cGMP analog
|
|
|
|
increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
activation
|
